Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

History Says Industry Needs Post-AER Bill Response Plan – Ullman

This article was originally published in The Tan Sheet

Executive Summary

The dietary supplement industry needs to have a "mechanism in place" to respond to actions industry opponents are likely to take following the passage of an AER bill, attorney Marc Ullman suggested at the SupplySide East trade show and conference in Secaucus, N.J. May 3

You may also be interested in...



Loss Of Sen. Kennedy Leaves Hole In HELP Committee, FDA Oversight

The passing of Sen. Ted Kennedy deprives the Senate of one of its most prolific figures in the area of health legislation and leaves open the chairmanship of the committee with FDA oversight

Loss Of Sen. Kennedy Leaves Hole In HELP Committee, FDA Oversight

The passing of Sen. Ted Kennedy deprives the Senate of one of its most prolific figures in the area of health legislation and leaves open the chairmanship of the committee with FDA oversight

Loss Of Sen. Kennedy Leaves Hole In HELP Committee, FDA Oversight

The passing of Sen. Ted Kennedy deprives the Senate of one of its most prolific figures in the area of health legislation and leaves open the chairmanship of the committee with FDA oversight

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099370

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel